BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BEBT-701 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BEBT-701\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07368608-557@assetmemo.bio
DTSTAMP:20261121T005832Z
DTSTART;VALUE=DATE:20281130
DTEND;VALUE=DATE:20281201
SUMMARY:BEBT-701: Phase 1/2 readout est. (NCT07368608)
DESCRIPTION:BEBT-701\, phase 1/2\, Hypertension.\nStudy: A Study of BEBT-70
 1 in Patients With Mild to Moderate Hypertension and Elevated Low-Density 
 Lipoprotein Cholesterol（LDL-C）\nEstimated primary completion: 30 Novem
 ber 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/bebt-701#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT073686
 08
URL:https://assetmemo.bio/drug/bebt-701#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
